Glen MacDonald
2020
In 2020, Glen MacDonald earned a total compensation of $674.7K as Chief Technology Officer at Eleven Biotherapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Bonus | $1,000 |
|---|---|
| Non-Equity Incentive Plan | $160,917 |
| Option Awards | $155,033 |
| Salary | $343,714 |
| Other | $14,067 |
| Total | $674,731 |
MacDonald received $343.7K in salary, accounting for 51% of the total pay in 2020.
MacDonald also received $1K in bonus, $160.9K in non-equity incentive plan, $155K in option awards and $14.1K in other compensation.
Rankings
In 2020, Glen MacDonald's compensation ranked 10,097th out of 13,090 executives tracked by ExecPay. In other words, MacDonald earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,097 out of 13,090 | 23rd |
Division Manufacturing | 4,333 out of 5,624 | 23rd |
Major group Chemicals And Allied Products | 1,787 out of 2,257 | 21st |
Industry group Drugs | 1,563 out of 1,957 | 20th |
Industry Pharmaceutical Preparations | 1,153 out of 1,462 | 21st |
Source: SEC filing on March 25, 2021.
MacDonald's colleagues
We found two more compensation records of executives who worked with Glen MacDonald at Eleven Biotherapeutics in 2020.